UB Paderborn / Katalog / Suche / in CDI

Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro

Neuroscience, 2014-10, Vol.278, p.62-69

2014

Link zum Volltext

Verfügbarkeit prüfen

AB0435 Immunosignature Technology Identifies Systemic Lupus Erythematosus from A Drop of Serum

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1056-1056

2016

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Clinical Drug Efficacy by Classification of Drug-Induced Genomic Expression Profiles in vitro

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (16), p.9608-9613

2003

Link zum Volltext

Verfügbarkeit prüfen

CO129 Effectiveness of a Prescription Digital Therapeutic of Cognitive-Behavioral Therapy for Insomnia in 2 Clinical Trials and in Real-World Clinical Settings: A Number Needed to Treat Analysis

Value in health, 2022-12, Vol.25 (12), p.S43-S43

2022

Link zum Volltext

Verfügbarkeit prüfen

Human fibroblast growth factor 20 (FGF-20; CG53135-05): A novel cytoprotectant with radioprotective potential

International journal of radiation biology, 2005-08, Vol.81 (8), p.567-579

2005

Link zum Volltext

Verfügbarkeit prüfen

0524 Web-Delivered CBT for Insomnia Intervention Improves Sleep Among Adults with Insomnia and Depressive Symptoms

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A200-A201

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D

International journal of clinical pharmacology and therapeutics, 2008-05, Vol.46 (5), p.236

2008

Link zum Volltext

Verfügbarkeit prüfen

A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action

The pharmacogenomics journal, 2005-01, Vol.5 (2), p.126-134

2005

Link zum Volltext

Verfügbarkeit prüfen

Growth and behavior of thyroid-deficient lizards ( Sceloporus undulatus)

General and comparative endocrinology, 1992-08, Vol.87 (2), p.312-324

1992

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3501-3501

2007

Link zum Volltext

Verfügbarkeit prüfen

The diabetes risk score outperforms fasting plasma glucose and glucose tolerance tests: combined results from the Inter99 and Botnia Studies

45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes,Vienna, Austria,2009-09-30 - 2009-10-02, 2009, Vol.52 (Suppl 1), p.7

2009

Link zum Volltext

Verfügbarkeit prüfen

181 POSTER A Phase Ib safety and pharmacodynamic study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors

European journal of cancer supplements, 2006-11, Vol.4 (12), p.57-57

2006

Link zum Volltext

Verfügbarkeit prüfen

Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development

Drug development research, 2004-06, Vol.62 (2), p.119-123

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

Biology of blood and marrow transplantation, 2006-02, Vol.12 (2), p.21-22

2006

Link zum Volltext

Verfügbarkeit prüfen

Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures

Scandinavian journal of rheumatology, 2023-05, Vol.52 (3), p.259-267

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of basement membrane laminins in vascular function

The international journal of biochemistry & cell biology, 2020-10, Vol.127, p.105823-105823, Article 105823

2020

Link zum Volltext

Verfügbarkeit prüfen

P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study

Rheumatology (Oxford, England), 2023-04, Vol.62 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Derivatives of Erythropoietin That Are Tissue Protective but Not Erythropoietic

Science (American Association for the Advancement of Science), 2004-07, Vol.305 (5681), p.239-242

2004

Link zum Volltext

Verfügbarkeit prüfen

RWD69 Healthcare Resource Use by European Patients Enrolled in RA-BE-REAL: 12 Month Data From a Multinational, Prospective, Observational Study of Patients With Rheumatoid Arthritis

Value in health, 2022-12, Vol.25 (12), p.S461-S462

2022

Link zum Volltext

Verfügbarkeit prüfen

SLE-key® rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP

Journal of immunological methods, 2016-02, Vol.429, p.1-6

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

Rheumatology and therapy., 2023-12, Vol.10 (6), p.1575-1595

2023

Link zum Volltext

Verfügbarkeit prüfen

The Sonic Hedgehog Pathway Mediates Carbamylated Erythropoietin-enhanced Proliferation and Differentiation of Adult Neural Progenitor Cells

The Journal of biological chemistry, 2007-11, Vol.282 (44), p.32462-32470

2007

Link zum Volltext

Verfügbarkeit prüfen

Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB

Cancer chemotherapy and pharmacology, 2007-08, Vol.60 (3), p.423-435

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacité et arrêts de traitement sous baricitinib dans la polyarthrite rhumatoïde selon l’âge du patient et le traitement antérieur: données sur 2 ans issues de la cohorte européenne de l’étude RA-BE-REAL

Revue du rhumatisme (Ed. française : 1993), 2023-12, Vol.90, p.A117-A118

2023

Link zum Volltext

Verfügbarkeit prüfen

The SLE-key test serological signature: new insights into the course of lupus

Rheumatology (Oxford, England), 2018-09, Vol.57 (9), p.1632-1640

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro

AB0435 Immunosignature Technology Identifies Systemic Lupus Erythematosus from A Drop of Serum

Prediction of Clinical Drug Efficacy by Classification of Drug-Induced Genomic Expression Profiles in vitro

CO129 Effectiveness of a Prescription Digital Therapeutic of Cognitive-Behavioral Therapy for Insomnia in 2 Clinical Trials and in Real-World Clinical Settings: A Number Needed to Treat Analysis

Human fibroblast growth factor 20 (FGF-20; CG53135-05): A novel cytoprotectant with radioprotective potential

0524 Web-Delivered CBT for Insomnia Intervention Improves Sleep Among Adults with Insomnia and Depressive Symptoms

A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D

A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action

Growth and behavior of thyroid-deficient lizards ( Sceloporus undulatus)

A phase Ib/II study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors

The diabetes risk score outperforms fasting plasma glucose and glucose tolerance tests: combined results from the Inter99 and Botnia Studies

181 POSTER A Phase Ib safety and pharmacodynamic study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors

Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures

The role of basement membrane laminins in vascular function

P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study

Derivatives of Erythropoietin That Are Tissue Protective but Not Erythropoietic

RWD69 Healthcare Resource Use by European Patients Enrolled in RA-BE-REAL: 12 Month Data From a Multinational, Prospective, Observational Study of Patients With Rheumatoid Arthritis

SLE-key® rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP

Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

The Sonic Hedgehog Pathway Mediates Carbamylated Erythropoietin-enhanced Proliferation and Differentiation of Adult Neural Progenitor Cells

Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB

Efficacité et arrêts de traitement sous baricitinib dans la polyarthrite rhumatoïde selon l’âge du patient et le traitement antérieur: données sur 2 ans issues de la cohorte européenne de l’étude RA-BE-REAL

The SLE-key test serological signature: new insights into the course of lupus

Suchergebnisse filtern